Journal of Vascular Surgery
Volume 51, Issue 6 , Pages 1574-1580.e1 , June 2010

Primary stenting for atherosclerotic renal artery stenosis

  • Olivier Steichen, MD

      Affiliations

    • Assistance Publique—Hôpitaux de Paris, Centre d'Investigations Cliniques, Hôpital Européen Georges Pompidou, Université Paris Descartes, Faculté de Médecine, Paris, France
    • ,
  • Laurence Amar, MD

      Affiliations

    • Service d'Hypertension Artérielle, Hôpital Européen Georges Pompidou, Université Paris Descartes, Faculté de Médecine, Paris, France
    • ,
  • Pierre-François Plouin, MD

      Affiliations

    • Service d'Hypertension Artérielle, Hôpital Européen Georges Pompidou, Université Paris Descartes, Faculté de Médecine, Paris, France
    • Corresponding Author InformationReprint requests: Prof Pierre-François Plouin, Service d'Hypertension Artérielle, Hôpital Européen Georges Pompidou, 20-40 rue Leblanc, 75015 Paris, France

Received 23 October 2009 ,Accepted 31 January 2010.

References 

  1. Baumgartner I, von Aesch K, Do DD, Triller J, Birrer M, Mahler F. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study. Radiology. 2000;216:498–505
  2. van de Ven PJG, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282–286
  3. Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Modder U, Godehardt E, et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg. 2009;49:667–674discussion 674-5
  4. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J, et al. Stent placement for renal arterial stenosis: where do we stand? (A meta-analysis). Radiology. 2000;216:78–85
  5. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–e654
  6. Arthurs Z, Starnes B, Cuadrado D, Sohn V, Cushner H, Andersen C. Renal artery stenting slows the rate of renal function decline. J Vasc Surg. 2007;45:726–731discussion 731-2
  7. Zalunardo N, Rose C, Starovoytov A, Djurdjev O, Fox R, Taylor P, et al. Incidental atherosclerotic renal artery stenosis diagnosed at cardiac catheterization: no difference in kidney function with or without stenting. Am J Nephrol. 2008;28:921–928
  8. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150:840–848
  9. Ziakka S, Ursu M, Poulikakos D, Papadopoulos C, Karakasis F, Kaperonis N, et al. Predictive factors and therapeutic approach of renovascular disease: four years' follow-up. Ren Fail. 2008;30:965–970
  10. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–1962
  11. Zeller T, Rastan A, Schwarzwalder U, Muller C, Frank U, Burgelin K, et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther. 2007;14:189–197
  12. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM. 2009;102:695–704
  13. Hegarty J, Wright JR, Kalra PR, Kalra PA. The heart in renovascular disease—an association demanding further investigation. Int J Cardiol. 2006;111:339–342
  14. Schwarzwalder U, Hauk M, Zeller T. RADAR—A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials. 2009;10:60
  15. Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145:901–912
  16. Singer GM, Setaro JF, Curtis JP, Remetz MS. Distal embolic protection during renal artery stenting: impact on hypertensive patients with renal dysfunction. J Clin Hypertens (Greenwich). 2008;10:830–836
  17. Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117:2752–2760
  18. Kanjwal K, Haller S, Steffes M, Virmani R, Shapiro JI, Burket MW, et al. Complete versus partial distal embolic protection during renal artery stenting. Catheter Cardiovasc Interv. 2009;73:725–730
  19. Zeller T, Muller C, Frank U, Burgelin K, Sinn L, Horn B, et al. Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv. 2003;60:1–6discussion 7-8
  20. Zeller T, Rastan A, Kliem M, Schwarzwalder U, Frank U, Burgelin K, et al. Impact of carbon coating on the restenosis rate after stenting of atherosclerotic renal artery stenosis. J Endovasc Ther. 2005;12:605–611
  21. Zahringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, et al. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther. 2007;14:460–468
  22. Nolan BW, Schermerhorn ML, Powell RJ, Rowell E, Fillinger MF, Rzucidlo EM, et al. Restenosis in gold-coated renal artery stents. J Vasc Surg. 2005;42:40–46
  23. Rees CR. Stents for atherosclerotic renovascular disease. J Vasc Interv Radiol. 1999;10:689–705
  24. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410–417
  25. Rivolta R, Bazzi C, Stradiotti P, Paparella M. Stenting of renal artery stenosis: is it beneficial in chronic renal failure?. J Nephrol. 2005;18:749–754
  26. Rocha-Singh K, Jaff MR, Lynne Kelley E. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv. 2008;72:853–862
  27. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Horn B, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther. 2004;11:95–106
  28. Garcia-Criado A, Gilabert R, Nicolau C, Real MI, Muntana X, Blasco J, et al. Value of Doppler sonography for predicting clinical outcome after renal artery revascularization in atherosclerotic renal artery stenosis. J Ultrasound Med. 2005;24:1641–1647
  29. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152:59–66
  30. Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7:275–279
  31. Gross CM, Kramer J, Waigand J, Uhlich F, Olthoff H, Luft FC, et al. Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1998;45:1–8
  32. Khosla S, Ahmed A, Siddiqui M, Trivedi A, Benatar D, Salem Y, et al. Safety of angiotensin-converting enzyme inhibitors in patients with bilateral renal artery stenosis following successful renal artery stent revascularization. Am J Ther. 2006;13:306–308
  33. van de Ven PJG, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Geyskes GG, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet. 1995;346:672–674
  34. Bloch MJ, Trost DW, Pickering TG, Sos TA, August P. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens. 1999;12:1–7
  35. Khosla S, White CJ, Collins TJ, Jenkins JS, Shaw D, Ramee SR. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol. 1997;80:363–366

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)00306-X

doi: 10.1016/j.jvs.2010.02.011

Journal of Vascular Surgery
Volume 51, Issue 6 , Pages 1574-1580.e1 , June 2010

Article Tools